Prospective randomized study for hydrotubation versus no hydrotubation before intrauterine insemination in unexplained infertility
Abstract
The purpose of the study was to investigate the value of hydrotubation before intrauterine insemination (IUI). In 228 patients with the diagnosis of unexplained infertility, ovarian stimulation was performed before IUI, using 100
mg of clomiphine citrate for 5
days from day 3 of the cycle and one ampoule of human menopausal gonadotrophin for 5
days from day 6 of the cycle. Folliculometry and determination of LH concentration in urine were performed daily until LH became positive, then randomization for hydrotubation before IUI versus no hydrotubation was performed. Fifteen patients were cancelled from the study due to poor response or stimulation of three or more follicles. A total of 213 patients were randomized as follows: 103 patients undergoing hydrotubation using 50
ml of saline and 110 patients with no hydrotubation. IUI was performed the following day and ongoing pregnancy occurred in 13 patients (12.6%) in the hydrotubation group and nine patients (8.2%) in the non-hydrotubation group with no significant difference (OR 1.66; 95% CI 0.62–4.63). In conclusion, hydrotubation before IUI does not improve pregnancy rate.
Keywords: hydrotubation, IUI, ovarian stimulation, pregnancy rate
To access this article, please choose from the options below
Mohamed Aboulghar obtained his Doctorate degree in Obstetrics and Gynecology in 1969 and has been Professor of Obstetrics and Gynecology in the Faculty of Medicine at Cairo University, Egypt since 1979. He continues to supervise post-graduate degrees there in Obstetrics and Gynecology and related subjects. He is also Clinical Director at the Egyptian IVF-ET Centre, Maadi, Cairo, Editor-in-Chief of the Middle East Fertility Society Journal and a regular reviewer for several international journals. He has organized scientific meetings in Egypt in collaboration with key European and American centres and has participated in many such meetings in the Middle East, Europe, and North America over the past 20
years.
PII: S1472-6483(10)00004-0
doi:10.1016/j.rbmo.2010.01.003
© 2010 Reproductive Healthcare Ltd. Published by Elsevier Inc All rights reserved.
